Showing results (1781-1790 of 3,888) with videos related to

Sort By:
Pageof 389
Cancer Biology & Therapy|February 22, 2014
Overexpression of DDR2 contributes to cell invasion and migration in head and neck squamous cell carcinomaJinke Xu, Wei Lu, Senlin Zhang, et al.
Cancer Biology & Therapy|February 22, 2014
Escherichia coli Nissle 1917-derived factors reduce cell death and late apoptosis and increase transepithelial electrical resistance in a model of 5-fluorouracil-induced intestinal epithelial cell damageHanru Wang, Susan E P Bastian, Ker Y Cheah, et al.
Cancer Biology & Therapy|February 15, 2014
Differentiation of glioblastoma multiforme stem-like cells leads to downregulation of EGFR and EGFRvIII and decreased tumorigenic and stem-like cell potentialMarie-Thérése Stockhausen, Karina Kristoffersen, Louise Stobbe, et al.
Cancer Biology & Therapy|March 28, 2008
Monoclonal antibodies target intracellular PRL phosphatases to inhibit cancer metastases in miceKe Guo, Jing Ping Tang, Cheng Peow Bobby Tan, et al.
Cancer Biology & Therapy|March 15, 2008
C. elegans as a model organism for in vivo screening in cancer: effects of human c-Met in lung cancer affect C. elegans vulva phenotypesShahid S Siddiqui, Sivakumar Loganathan, Soundararajan Krishnaswamy, et al.
Cancer Biology & Therapy|March 19, 2008
The effectiveness of retinoic acid treatment in bladder cancer: impact on recurrence, survival and TGFalpha and VEGF as end-point biomarkersDiaa A Hameed, Tarek H el-Metwally
Cancer Biology & Therapy|March 19, 2008
HIF-1alpha and STAT3 client proteins interacting with the cancer chaperone Hsp90: therapeutic considerationsHanna Leah Kim, Marco Cassone, Laszlo Otvos, et al.
Cancer Biology & Therapy|February 26, 2008
Comparison of radiolabeled choline and ethanolamine as probe for cancer detectionAkiva Mintz, Limin Wang, Datta E Ponde
Cancer Biology & Therapy|October 23, 2018
PDGFRα expression as a novel therapeutic marker in well-differentiated neuroendocrine tumorsElisabetta Cavalcanti, Antonia Ignazzi, Francesco De Michele, et al.
Cancer Biology & Therapy|October 19, 2018
FSTL1 enhances chemoresistance and maintains stemness in breast cancer cells via integrin β3/Wnt signaling under miR-137 regulationShaoqiang Cheng, Yuanxi Huang, Chun Lou, et al.
Pageof 389